Blood Work Explained
HOW YOUR MARKERS CONNECT
Patterns in your blood work — why experienced providers read panels by looking for multiple markers pointing in the same direction, and what the six most common patterns mean for you.
Medically reviewed by Missy Zammichieli, DNP, APRN, FNP-BC · Updated March 2, 2026
THE BOTTOM LINE
- • Your blood work results are not a collection of independent numbers.
- • Your metabolism influences your hormones. Your hormones influence your lipids. Inflammation affects insulin sensitivity, which affects triglycerides, which affect cardiovascular risk.
- • Experienced providers read panels by looking for patterns — multiple markers pointing in the same direction — because that is where the real clinical insights are.
- • This article walks through the most common patterns and what they mean for you.
INTRODUCTION
Most patient portals present results as a list of isolated numbers, each flagged independently as “normal” or “abnormal.” This misses what providers actually do: look for patterns.
A fasting glucose of 102 mg/dL means something different alongside a triglyceride level of 85 than alongside triglycerides of 250 and an hs-CRP of 4.5.
This article covers six well-established patterns. The goal is not self-diagnosis — that requires clinical training — but to help you understand why certain markers are evaluated together and what it means when multiple results point in the same direction.
PATTERN 1: METABOLIC RESISTANCE
The markers: Elevated fasting glucose + elevated fasting insulin + elevated triglycerides + elevated hs-CRP
What it means: When these four markers are elevated together, they point to insulin resistance — your cells are responding less effectively to insulin, so your pancreas has to produce more of it to keep blood sugar in check. This is not an on/off switch but a spectrum, and it often develops years or decades before blood sugar crosses into the diabetic range.
Why these markers travel together: Insulin resistance drives triglyceride production in the liver, promotes inflammatory signaling from fat tissue (raising hs-CRP), and forces the pancreas to overproduce insulin to keep glucose in check — until that mechanism fails and glucose rises too. All four trending upward together is far more informative than any single result.
Why it matters for you: This pattern is one of the most responsive to lifestyle changes in clinical medicine. The Diabetes Prevention Program showed that 7% body weight reduction and 150 minutes/week of physical activity cut progression to type 2 diabetes by 58% — benefits that persisted over 15 years of follow-up.
What can improve it:
- • Body composition changes (even modest fat loss makes a measurable difference)
- • Regular physical activity (150+ minutes/week of moderate-to-vigorous exercise)
- • Reducing refined carbohydrates and processed foods
- • Improving sleep quality
PATTERN 2: CARDIOVASCULAR LIPID PATTERN
The markers: Elevated LDL-C + elevated ApoB + elevated triglycerides, with or without elevated Lp(a)
What it means: When standard LDL cholesterol, ApoB, and triglycerides are all elevated, it indicates a high burden of dangerous cholesterol particles in your bloodstream. When Lp(a) is also elevated, a genetic risk factor is layered on top.
When Your Numbers Agree vs. When They Don’t Match
The key question is whether LDL-C and ApoB tell the same story.
- • When they agree: LDL-C and ApoB are proportionally elevated (or normal). Standard LDL-C is giving you an accurate picture.
- • When they don’t match: LDL-C looks normal but ApoB is elevated — meaning there are many smaller, denser cholesterol particles that LDL-C misses. When these disagree, cardiovascular risk tracks with ApoB, not LDL-C. This mismatch is especially common in people with insulin resistance and elevated triglycerides.
Why it matters for you: Genetic studies show cardiovascular risk from LDL depends on cumulative lifetime exposure — both how high and how long. Patterns identified earlier give you more time to act.
The Lp(a) layer: About 20% of people have elevated Lp(a), which is largely genetic. Lifestyle and most medications have minimal impact on it. When elevated Lp(a) co-occurs with an unfavorable LDL/ApoB pattern, the combined risk exceeds what either suggests alone. Guidelines recommend measuring Lp(a) at least once in every adult’s lifetime.
What can improve it:
- • Dietary changes (reducing saturated fat, increasing fiber)
- • Regular exercise
- • Statin therapy when indicated (discuss with your provider)
- • Addressing insulin resistance if present (which can shift LDL particle size)
- • Lp(a) is largely genetic and not responsive to lifestyle changes — but knowing about it informs overall risk management
PATTERN 3: THYROID-LIPID CONNECTION
The markers: Elevated TSH (or borderline-high TSH) + elevated LDL cholesterol + elevated total cholesterol, sometimes with fatigue and weight changes
What it means: Thyroid hormones directly control how quickly your liver clears LDL cholesterol from the bloodstream. When thyroid function decreases, your liver clears less LDL, and cholesterol levels rise. Even subclinical hypothyroidism (elevated TSH with normal free T4) is associated with increased total cholesterol and LDL.
The clinical takeaway: an elevated LDL may have a thyroid cause rather than — or in addition to — a dietary or genetic one.
Why it matters for you: If LDL cholesterol is elevated and TSH is also elevated, addressing thyroid function may improve your lipid profile without additional cholesterol-targeted treatment. Studies show thyroid hormone replacement in hypothyroid patients reduces LDL by an average of 10–30%, depending on severity.
Additional thyroid ripple effects: Thyroid hormones also influence sex hormone-binding globulin (SHBG). Low thyroid function lowers SHBG, which changes how much testosterone and estradiol are available to your tissues — affecting body composition, energy, and metabolic function. One upstream change (thyroid) can cascade through multiple results on your panel.
What can improve it:
- • Thyroid hormone replacement when indicated
- • Regular monitoring of both thyroid and lipid markers
- • Awareness that lipid changes may resolve once thyroid function is optimized
PATTERN 4: THE INFLAMMATION-METABOLIC CYCLE
The markers: Elevated hs-CRP + elevated fasting insulin + elevated fasting glucose + elevated triglycerides
What it means: Inflammation and insulin resistance form a self-reinforcing cycle. Fat tissue — especially belly fat — produces inflammatory signals that make cells less responsive to insulin. Higher insulin triggers more inflammation, which worsens insulin resistance further.
Why it matters for you: When hs-CRP is elevated alongside metabolic markers, it suggests this cycle is active — distinct from hs-CRP being elevated alone (which might just reflect a recent illness). The co-occurrence tells your provider more about what is driving the inflammation. Interventions addressing both metabolic function and inflammation tend to produce greater improvements than targeting either alone.
What can improve it:
- • Fat loss, particularly visceral fat
- • Regular exercise (both cardiovascular and resistance training)
- • Anti-inflammatory dietary patterns (Mediterranean-style, reduced processed foods)
- • Improved sleep
- • Reducing or quitting smoking
PATTERN 5: IRON-CBC CONNECTION
The markers: Low MCV + high RDW + low hemoglobin, sometimes with low ferritin and high TIBC
What it means: Iron deficiency leaves a signature across the complete blood count (CBC), often before symptoms appear. As iron depletes, your body produces smaller red blood cells (low MCV) because there is not enough iron for normal hemoglobin production. Red cell size variation increases (high RDW) as a mix of normal older cells and smaller new cells circulate together. Hemoglobin drops as deficiency worsens.
Why it matters for you: Low hemoglobin alone has many possible causes. But low hemoglobin with low MCV, high RDW, low ferritin, and high TIBC creates a specific pattern pointing to iron deficiency. Conversely, low hemoglobin with high MCV suggests B12 or folate deficiency — a completely different cause requiring a different approach.
One nuance: Ferritin rises with inflammation. If you have both iron deficiency and active inflammation, ferritin may look normal despite depleted stores — which is why providers check it alongside CRP and the full CBC.
What can improve it:
- • Iron-rich foods (red meat, leafy greens, legumes) or supplementation
- • Addressing any underlying cause of iron loss (heavy menstruation, GI issues)
- • Vitamin C to enhance iron absorption
- • Follow-up testing to confirm repletion
PATTERN 6: HORMONES-METABOLIC LINK
The markers: Low SHBG + elevated fasting insulin + changes in testosterone + altered body composition markers
What it means: Sex hormone-binding globulin (SHBG) is not just a transport protein — it is a sensitive barometer of metabolic status. When insulin is high, SHBG goes down. A low SHBG often signals developing insulin resistance.
Why it matters for you: When SHBG is low alongside elevated fasting insulin or other metabolic markers, it reinforces the metabolic pattern. A low SHBG in an otherwise metabolically healthy person warrants a different interpretation.
Testosterone and Body Composition
The relationship between testosterone and metabolic health is bidirectional. Low testosterone in men is associated with increased belly fat, which worsens insulin resistance, which further suppresses testosterone — another self-reinforcing cycle. Increased visceral fat boosts aromatase activity (the enzyme that converts testosterone to estradiol), which can lower testosterone independent of testicular function.
Interpreting Testosterone with SHBG
A “low-normal” testosterone is more concerning when SHBG is also low (because low SHBG means more should be free — so if total testosterone is still low, free testosterone may be very low). Conversely, “normal” testosterone alongside very high SHBG may mean less is actually available than the number suggests. This is why hormonal markers are best evaluated as a group.
What can improve it:
- • Addressing insulin resistance (the upstream driver) through diet and exercise
- • Body composition improvements (fat loss, muscle gain)
- • Sleep optimization (testosterone production is sleep-dependent)
- • Evaluation for TRT if levels remain low after metabolic optimization
WHAT YOUR PROVIDER LOOKS FOR
Providers evaluate markers in clusters, not isolation. They look for:
- • Directional consistency: Three mildly abnormal results pointing the same way may matter more than one markedly abnormal result alone.
- • Metabolic context for lipids: Lipid values mean different things alongside insulin resistance, thyroid dysfunction, or inflammation.
- • Upstream vs. downstream: Some abnormalities are causes, others are consequences. Thyroid dysfunction causing lipid elevation is a different situation than primary high cholesterol with normal thyroid.
- • Trajectories over time: A single draw is a snapshot. Comparing to prior panels shows whether markers are gradually worsening or acutely changed.
This is why comprehensive panels provide more value than the sum of their parts. Each marker adds context to the others.
References
- 1. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173-194.
- 2. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.
- 3. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-867.
- 4. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. Circulation. 2005;112(17):2735-2752.
- 5. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002;346(6):393-403.
- 6. Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up. Lancet Diabetes & Endocrinology. 2015;3(11):866-875.
- 7. Sniderman AD, Williams K, Contois JH, et al. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circulation: Cardiovascular Quality and Outcomes. 2011;4(3):337-345.
- 8. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: evidence from genetic, epidemiologic, and clinical studies. European Heart Journal. 2017;38(32):2459-2472.
- 9. Tsimikas S, Fazio S, Ferdinand KC, et al. NHLBI Working Group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis. Journal of the American College of Cardiology. 2018;71(2):177-192.
- 10. Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287-293.
- 11. Pearce EN. Update in lipid alterations in subclinical hypothyroidism. Journal of Clinical Endocrinology & Metabolism. 2012;97(2):326-333.
- 12. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocrine Reviews. 2010;31(5):702-755.
- 13. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. Journal of Clinical Investigation. 2006;116(7):1793-1801.
- 14. Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. JAMA. 2004;292(12):1440-1446.
- 15. Camaschella C. Iron-deficiency anemia. New England Journal of Medicine. 2015;372(19):1832-1843.
- 16. Green R, Allen LH, Bjorke-Monsen AL, et al. Vitamin B12 deficiency. Nature Reviews Disease Primers. 2017;3:17040.
- 17. Selva DM, Hogeveen KN, Innis SM, Hammond GL. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. Journal of Clinical Investigation. 2007;117(12):3979-3987.
- 18. Kelly DM, Jones TH. Testosterone and obesity. Obesity Reviews. 2015;16(7):581-606.
- 19. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology & Metabolism. 1999;84(10):3666-3672.
UNDERSTAND YOUR NUMBERS
Isolated numbers miss the story. Get a comprehensive panel and a provider who reads the patterns — not just the flags.
Book Consultation